These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 19004063)

  • 21. [Use of antimetabolites in diseases of auto-aggression].
    Romiti N
    Hospital (Rio J); 1968 Jan; 73(1):71-8. PubMed ID: 5308511
    [No Abstract]   [Full Text] [Related]  

  • 22. Trigeminal neuropathy responding to systemic corticosteroids and methotrexate in a patient with diffuse cutaneous systemic sclerosis.
    Miguel D; Darr-Foit S; Tittelbach J; Elsner P
    Eur J Dermatol; 2017 Feb; 27(1):82-83. PubMed ID: 27748258
    [No Abstract]   [Full Text] [Related]  

  • 23. Observational data to study medication outcomes in systemic sclerosis.
    Hudson M; Baron M; ; Steele R
    J Rheumatol; 2011 Mar; 38(3):575-7. PubMed ID: 21362793
    [No Abstract]   [Full Text] [Related]  

  • 24. [Studies in 25 patients with progressive systemic scleroderma treated by long-term administration of griseofulvin].
    Giordano M; Ara M; Capelli L; Tirri G; Pettinato G; Vatti M
    Minerva Med; 1973 Jun; 64(46):2451-66. PubMed ID: 4579328
    [No Abstract]   [Full Text] [Related]  

  • 25. Scleroderma in children.
    Zulian F
    Pediatr Clin North Am; 2005 Apr; 52(2):521-45, vii. PubMed ID: 15820378
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rituximab: a potential therapeutic advance in scleroderma: what is the evidence?
    Simms RW; Lafyatis R
    Rheumatology (Oxford); 2010 Feb; 49(2):201-2. PubMed ID: 20032221
    [No Abstract]   [Full Text] [Related]  

  • 27. Juvenile-onset systemic sclerosis: children are not small adults.
    Denton CP; Derrett-Smith EC
    Rheumatology (Oxford); 2009 Feb; 48(2):96-7. PubMed ID: 19028745
    [No Abstract]   [Full Text] [Related]  

  • 28. Cyclophosphamide in scleroderma lung disease.
    Sullivan KM; McSweeney PA; Nash RA
    N Engl J Med; 2006 Sep; 355(11):1173-4; author reply 1174. PubMed ID: 16977701
    [No Abstract]   [Full Text] [Related]  

  • 29. Chronic leg ulceration as the presenting feature of diffuse systemic sclerosis in childhood.
    Wahezi DM; Ilowite NT; Kenney-Riley KM; Belamarich PF
    J Pediatr; 2011 Oct; 159(4):698. PubMed ID: 21784448
    [No Abstract]   [Full Text] [Related]  

  • 30. Scleroderma treatment differs between experts and general rheumatologists.
    Pope JE; Ouimet JM; Krizova A
    Arthritis Rheum; 2006 Feb; 55(1):138-45. PubMed ID: 16463426
    [No Abstract]   [Full Text] [Related]  

  • 31. Cyclophosphamide in scleroderma lung disease.
    Andreu JL; Silva L
    N Engl J Med; 2006 Sep; 355(11):1173; author reply 1174. PubMed ID: 16977700
    [No Abstract]   [Full Text] [Related]  

  • 32. Stem cell transplantation: a treatment option for severe systemic sclerosis?
    van Laar JM; Farge D; Tyndall A
    Ann Rheum Dis; 2008 Dec; 67 Suppl 3():iii35-8. PubMed ID: 19022811
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Methotrexate for the treatment of early diffuse scleroderma: comment on the article by Pope et al.
    Lehman TJ
    Arthritis Rheum; 2002 Mar; 46(3):845. PubMed ID: 11920427
    [No Abstract]   [Full Text] [Related]  

  • 34. Systemic sclerosis and localized scleroderma in childhood.
    Zulian F
    Rheum Dis Clin North Am; 2008 Feb; 34(1):239-55; ix. PubMed ID: 18329543
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel treatment approaches to fibrosis in scleroderma.
    Distler J; Distler O
    Rheum Dis Clin North Am; 2008 Feb; 34(1):145-59; vii. PubMed ID: 18329537
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anti-inflammatory: new trends in the treatment of the patient with systemic sclerosis.
    Valentini G; Cerinic MM
    Expert Opin Emerg Drugs; 2008 Jun; 13(2):227-36. PubMed ID: 18537518
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Shifting our thinking about uncommon disease trials: the case of methotrexate in scleroderma.
    Johnson SR; Feldman BM; Pope JE; Tomlinson GA
    J Rheumatol; 2009 Feb; 36(2):323-9. PubMed ID: 19040308
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Treatment of scleroderma].
    Guillevin L; Ortonne JP
    Ann Med Interne (Paris); 1983; 134(8):754-65. PubMed ID: 6364917
    [No Abstract]   [Full Text] [Related]  

  • 39. Methotrexate treatment in scleroderma.
    van den Hoogen FH; Boerbooms AM; van de Putte LB
    Am J Med; 1989 Jul; 87(1):116-7. PubMed ID: 2741971
    [No Abstract]   [Full Text] [Related]  

  • 40. Current approaches to the management of early active diffuse scleroderma skin disease.
    Nihtyanova SI; Denton CP
    Rheum Dis Clin North Am; 2008 Feb; 34(1):161-79; viii. PubMed ID: 18329538
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.